These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15628305)

  • 21. Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole.
    Kartsonis N; DiNubile MJ; Bartizal K; Hicks PS; Ryan D; Sable CA
    J Acquir Immune Defic Syndr; 2002 Oct; 31(2):183-7. PubMed ID: 12394797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caspofungin: a review of its use in the treatment of fungal infections.
    McCormack PL; Perry CM
    Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
    Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candida glabrata endophthalmitis treated successfully with caspofungin.
    Sarria JC; Bradley JC; Habash R; Mitchell KT; Kimbrough RC; Vidal AM
    Clin Infect Dis; 2005 Mar; 40(5):e46-8. PubMed ID: 15714407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caspofungin in kidney transplant recipients with refractory invasive candidiasis.
    Veroux M; Corona D; Macarone M; Gagliano M; Giuffida G; Veroux P
    Nephrol Dial Transplant; 2007 May; 22(5):1487-9. PubMed ID: 17210588
    [No Abstract]   [Full Text] [Related]  

  • 28. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida tropicalis in human disease.
    Chai LY; Denning DW; Warn P
    Crit Rev Microbiol; 2010 Nov; 36(4):282-98. PubMed ID: 20883082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.
    Golan Y; Wolf MP; Pauker SG; Wong JB; Hadley S
    Ann Intern Med; 2005 Dec; 143(12):857-69. PubMed ID: 16365467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caspofungin for the treatment of azole resistant candidemia in a premature infant.
    Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK
    J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caspofungin in the treatment of oropharyngeal candidiasis.
    Garbino J; Lew D; Hirschel B; Rohner P
    Int J Clin Pract; 2003 Mar; 57(2):143-4. PubMed ID: 12661800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caspofungin for invasive candidiasis at a tertiary care medical center.
    Zaas AK; Dodds Ashley ES; Alexander BD; Johnson MD; Perfect JR
    Am J Med; 2006 Nov; 119(11):993.e1-6. PubMed ID: 17071169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans.
    Victorio GB; Bourdon LMB; Benavides LG; Huerta-Olvera SG; Plascencia A; Villanueva J; Martinez-Lopez E; Hernández-Cañaveral II
    Mem Inst Oswaldo Cruz; 2017 May; 112(5):370-375. PubMed ID: 28443984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B.
    Sorà F; Chiusolo P; Piccirillo N; Pagano L; Laurenti L; Farina G; Sica S; Leone G
    Clin Infect Dis; 2002 Nov; 35(9):1135-6. PubMed ID: 12384850
    [No Abstract]   [Full Text] [Related]  

  • 36. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients.
    Veroux M; Macarone M; Fiamingo P; Cappello D; Gagliano M; Di Mare M; Vizcarra D; Spataro M; Giuffrida G; Sorbello M; Severino V; Veroux P
    Transplant Proc; 2006 May; 38(4):1037-9. PubMed ID: 16757256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
    Fong IW; Bannatyne RM; Cheng PC
    Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of candidemia on caspofungin therapy: a case report.
    Cheung C; Guo Y; Gialanella P; Feldmesser M
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
    Agnelli C; Guinea J; Valerio M; Escribano P; Bouza E; Muñoz P
    Rev Esp Quimioter; 2019 Aug; 32(4):395-397. PubMed ID: 31327188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.